NECLIFEPharmaceuticals
Nectar Lifesciences Ltd — Balance Sheet
₹9.30
-7.74%
Nectar Lifesciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 22.43 Cr | 22.43 Cr | 22.43 Cr | 22.43 Cr | — |
| Share Issued | 22.43 Cr | 22.43 Cr | 22.43 Cr | 22.43 Cr | — |
| Net Debt | 562.80 Cr | 615.75 Cr | 736.28 Cr | 842.15 Cr | — |
| Total Debt | 582.02 Cr | 635.54 Cr | 753.83 Cr | 859.93 Cr | — |
| Tangible Book Value | 899.60 Cr | 1.02K Cr | 1.02K Cr | 1.04K Cr | — |
| Invested Capital | 1.54K Cr | 1.70K Cr | 1.82K Cr | 1.95K Cr | — |
| Working Capital | 216.05 Cr | 311.02 Cr | 340.26 Cr | 351.02 Cr | — |
| Net Tangible Assets | 899.60 Cr | 1.02K Cr | 1.02K Cr | 1.04K Cr | — |
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Common Stock Equity | 956.11 Cr | 1.07K Cr | 1.06K Cr | 1.09K Cr | — |
| Total Capitalization | 1.02K Cr | 1.21K Cr | 1.29K Cr | 1.38K Cr | — |
| Total Equity Gross Minority Interest | 956.11 Cr | 1.07K Cr | 1.06K Cr | 1.09K Cr | — |
| Stockholders Equity | 956.11 Cr | 1.07K Cr | 1.06K Cr | 1.09K Cr | — |
| Other Equity Interest | 933.68 Cr | 1.05K Cr | 1.04K Cr | 1.07K Cr | — |
| Capital Stock | 22.43 Cr | 22.43 Cr | 22.43 Cr | 22.43 Cr | — |
| Common Stock | 22.43 Cr | 22.43 Cr | 22.43 Cr | 22.43 Cr | — |
| Total Liabilities Net Minority Interest | 1.09K Cr | 1.12K Cr | 1.12K Cr | 1.30K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 69.58 Cr | 148.99 Cr | 233.69 Cr | 299.10 Cr | — |
| Other Non Current Liabilities | 0.73 Cr | 0.75 Cr | 10000.00 | 0.83 Cr | — |
| Non Current Deferred Revenue | 0.00 | 0.75 Cr | 0.77 Cr | 0.80 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt And Capital Lease Obligation | 60.13 Cr | 140.31 Cr | 226.47 Cr | 291.07 Cr | — |
| Long Term Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt | 60.13 Cr | 140.31 Cr | 226.47 Cr | 291.07 Cr | — |
| Long Term Provisions | 8.73 Cr | 7.94 Cr | 6.45 Cr | 6.39 Cr | — |
| Current Liabilities | 1.02K Cr | 972.82 Cr | 890.93 Cr | 1.00K Cr | — |
| Other Current Liabilities | 8.84 Cr | 20000.00 | 8.59 Cr | 46.27 Cr | — |
| Current Debt And Capital Lease Obligation | 521.90 Cr | 495.23 Cr | 527.36 Cr | 568.85 Cr | — |
| Current Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Debt | 521.90 Cr | 495.23 Cr | 527.36 Cr | 568.85 Cr | — |
| Current Provisions | 2.92 Cr | 2.22 Cr | 1.86 Cr | 1.70 Cr | — |
| Payables | 438.12 Cr | 454.50 Cr | 348.74 Cr | 418.32 Cr | — |
| Total Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Payable | 438.12 Cr | 419.66 Cr | 318.75 Cr | 376.65 Cr | — |
| Total Assets | 2.05K Cr | 2.19K Cr | 2.19K Cr | 2.39K Cr | — |
| Total Non Current Assets | 809.64 Cr | 907.22 Cr | 958.03 Cr | 1.04K Cr | — |
| Other Non Current Assets | 52.79 Cr | 178.44 Cr | 186.54 Cr | 212.50 Cr | — |
| Non Current Deferred Taxes Assets | 55.04 Cr | 7.48 Cr | 20.57 Cr | 2.80 Cr | — |
| Other Investments | 0.24 Cr | 0.24 Cr | 0.24 Cr | 0.24 Cr | — |
| Investmentin Financial Assets | 3.25 Cr | 0.23 Cr | 0.23 Cr | 0.23 Cr | — |
| Available For Sale Securities | 3.25 Cr | 0.23 Cr | 0.23 Cr | 0.23 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | — | — | — |
| Investment Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 56.50 Cr | 52.39 Cr | 49.33 Cr | 43.02 Cr | — |
| Other Intangible Assets | 56.50 Cr | 52.39 Cr | 49.33 Cr | 43.02 Cr | — |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE | 633.33 Cr | 656.06 Cr | 690.43 Cr | 765.17 Cr | — |
| Gross PPE | 633.33 Cr | 1.47K Cr | 1.45K Cr | 1.48K Cr | — |
| Construction In Progress | 56.73 Cr | 65.75 Cr | 77.78 Cr | 85.10 Cr | — |
| Other Properties | 576.60 Cr | 209.38 Cr | 204.08 Cr | 198.25 Cr | — |
| Current Assets | 1.24K Cr | 1.28K Cr | 1.23K Cr | 1.35K Cr | — |
| Other Current Assets | 173.82 Cr | 4.79 Cr | 4.52 Cr | 4.59 Cr | — |
| Inventory | 690.16 Cr | 709.15 Cr | 672.60 Cr | 659.86 Cr | — |
| Other Receivables | 0.86 Cr | 43.23 Cr | 96.43 Cr | 67.45 Cr | — |
| Taxes Receivable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Receivable | 345.48 Cr | 379.19 Cr | 279.61 Cr | 446.98 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 27.26 Cr | 20.28 Cr | 17.87 Cr | 18.23 Cr | — |
| Other Short Term Investments | 8.04 Cr | 0.49 Cr | 0.31 Cr | 0.46 Cr | — |
| Cash And Cash Equivalents | 19.22 Cr | 19.79 Cr | 17.55 Cr | 17.77 Cr | — |
| Retained Earnings | — | 703.92 Cr | 699.27 Cr | 719.15 Cr | 696.70 Cr |
| Additional Paid In Capital | — | 328.80 Cr | 328.80 Cr | 328.80 Cr | 328.80 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 7.94 Cr | 6.45 Cr | 6.39 Cr | 7.74 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 7.87 Cr | 7.53 Cr | 6.50 Cr | 7.00 Cr |
| Other Payable | — | 34.83 Cr | 29.96 Cr | 41.63 Cr | 53.13 Cr |
| Dividends Payable | — | 0.02 Cr | 0.03 Cr | 0.03 Cr | 0.04 Cr |
| Non Current Prepaid Assets | — | 4.46 Cr | 3.58 Cr | 4.43 Cr | 4.38 Cr |
| Accumulated Depreciation | — | -812.61 Cr | -763.18 Cr | -716.06 Cr | -667.91 Cr |
| Machinery Furniture Equipment | — | 993.99 Cr | 976.50 Cr | 968.97 Cr | 950.71 Cr |
| Buildings And Improvements | — | 180.32 Cr | 176.01 Cr | 177.30 Cr | 175.03 Cr |
| Land And Improvements | — | 19.23 Cr | 19.23 Cr | 51.60 Cr | 80.64 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.02 Cr | 0.03 Cr | 0.03 Cr | 0.04 Cr |
| Prepaid Assets | — | 127.17 Cr | 160.13 Cr | 157.71 Cr | 198.02 Cr |
| Other Inventories | — | 14.24 Cr | 16.00 Cr | 17.49 Cr | 12.98 Cr |
| Finished Goods | — | 45.85 Cr | 20.73 Cr | 113.03 Cr | 162.60 Cr |
| Work In Process | — | 538.74 Cr | 515.55 Cr | 371.03 Cr | 298.18 Cr |
| Raw Materials | — | 110.32 Cr | 120.31 Cr | 158.31 Cr | 114.14 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | 0.00 | — |
| Gross Accounts Receivable | — | 379.19 Cr | 279.61 Cr | 446.98 Cr | 374.83 Cr |
| Cash Equivalents | — | 17.52 Cr | 15.43 Cr | 13.40 Cr | 23.64 Cr |
| Cash Financial | — | 2.27 Cr | 2.12 Cr | 4.38 Cr | 1.86 Cr |
| Minority Interest | — | — | 0.00 | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Nectar Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.